Drug Research
New BioAccelerator Expands Biomanufacturing Capacity for Canada
The Governments of Canada and Prince Edward Island (PEI) will invest $50 million in the BioAccelerator, the largest single investment in economic development infrastructure in PEI history.
The announcement was made by Ginette Petitpas Taylor, Minister of Official Languages, who...
Drug Research
BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors (TCRs).
The platform is expected to be deployed via a collaborative model with pharmaceutical and...
Drug Research
Lonza Completes Expansion of Conjugation Facility in Visp
Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland.
The expansion includes two manufacturing suites and supporting infrastructure to support an extended customer portfolio, including companies entering...
Drug Research
HPAPI Worldwide Market Is Booming – To Stay Today, Forever
As per a market report by Reportlinker, the worldwide highly potent active pharmaceutical ingredient- HPAPI sector is anticipated to breach the $34.04 billion mark by 2026 at a CAGR of around 8.5%.
HPAPIs are substances that cause a biological response...
Drug Research
Cancer Vaccine Redesign – A Transformation In The Making
Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The researchers used chemistry and nanotechnology to alter the structural placement of adjuvants and antigens on...
Drug Research
RMAT Status Given To Cardiac Gene Therapy – A First From FDA
The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes to the treatment of Danon disease, has been granted by the US Food and Drug Administration.
According to Dr. Gaurav...
Drug Research
Evotec, Related Sciences expand integrated drug discovery and development partnership
Evotec SE announced that the company has extended and expanded its integrated multi-target drug discovery agreement with data-driven biotech creation firm, Related Sciences (RS), to continue to grow their joint portfolio of drug development candidates through 2030, leveraging Evotec’s...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read